Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Oncology (Williston Park, N.Y.)
|
May 21, 2014
Palliative radiotherapy for prostate cancer
Matthew J Boyer, Joseph K Salama, W Robert Lee
Thoracic Surgery Clinics
|
November 28, 2015
Ablative Approaches for Pulmonary Metastases
Matthew J Boyer, Umberto Ricardi, David Ball, et al.
Prostate Cancer and Prostatic Diseases
|
February 28, 2023
Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: a secondary analysis of RTOG 0415
David J Carpenter, Joseph K Salama, W Robert Lee, et al.
Radiation Oncology (London, England)
|
January 15, 2017
Toxicity and quality of life report of a phase II study of stereotactic body radiotherapy (SBRT) for low and intermediate risk prostate cancer
Matthew J Boyer, Michael A Papagikos, Rex Kiteley, et al.
Cancer Research
|
January 7, 2006
Hematopoietic stem cells are not the direct target of spontaneous leukemic transformation in p18(INK4C)-null reconstituted mice
Youzhong Yuan, Hui Yu, Matthew J Boyer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 28, 2017
Improved Survival of Stage I Non-Small Cell Lung Cancer: A VA Central Cancer Registry Analysis
Matthew J Boyer, Christina D Williams, David H Harpole, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 2, 2026
Outcomes of 5 versus 10 Fraction Radiation Therapy for Hepatocellular Carcinoma at a Veteran Affairs Hospital
Jamiluddin J Qazi, Abhishek Kumar, Devon Godfrey, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 7, 2009
ADAR1 is required for hematopoietic progenitor cell survival via RNA editing
Richard XuFeng, Matthew J Boyer, Hongmei Shen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 8, 2020
Survival Advantage With Adjuvant Chemotherapy for Locoregionally Advanced Rectal Cancer: A Veterans Health Administration Analysis
Daphna Y Spiegel, Matthew J Boyer, Julian C Hong, et al.
Cancer
|
November 25, 2025
Prognostic significance of magnetic resonance imaging-detected extraprostatic extension in localized prostate cancer
Abhishek Kumar, Dominic A LaBella, Michael C Snider, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Oncology (Williston Park, N.Y.)
|
May 21, 2014
Palliative radiotherapy for prostate cancer
Matthew J Boyer, Joseph K Salama, W Robert Lee
Thoracic Surgery Clinics
|
November 28, 2015
Ablative Approaches for Pulmonary Metastases
Matthew J Boyer, Umberto Ricardi, David Ball, et al.
Prostate Cancer and Prostatic Diseases
|
February 28, 2023
Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: a secondary analysis of RTOG 0415
David J Carpenter, Joseph K Salama, W Robert Lee, et al.
Radiation Oncology (London, England)
|
January 15, 2017
Toxicity and quality of life report of a phase II study of stereotactic body radiotherapy (SBRT) for low and intermediate risk prostate cancer
Matthew J Boyer, Michael A Papagikos, Rex Kiteley, et al.
Cancer Research
|
January 7, 2006
Hematopoietic stem cells are not the direct target of spontaneous leukemic transformation in p18(INK4C)-null reconstituted mice
Youzhong Yuan, Hui Yu, Matthew J Boyer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 28, 2017
Improved Survival of Stage I Non-Small Cell Lung Cancer: A VA Central Cancer Registry Analysis
Matthew J Boyer, Christina D Williams, David H Harpole, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 2, 2026
Outcomes of 5 versus 10 Fraction Radiation Therapy for Hepatocellular Carcinoma at a Veteran Affairs Hospital
Jamiluddin J Qazi, Abhishek Kumar, Devon Godfrey, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 7, 2009
ADAR1 is required for hematopoietic progenitor cell survival via RNA editing
Richard XuFeng, Matthew J Boyer, Hongmei Shen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 8, 2020
Survival Advantage With Adjuvant Chemotherapy for Locoregionally Advanced Rectal Cancer: A Veterans Health Administration Analysis
Daphna Y Spiegel, Matthew J Boyer, Julian C Hong, et al.
Cancer
|
November 25, 2025
Prognostic significance of magnetic resonance imaging-detected extraprostatic extension in localized prostate cancer
Abhishek Kumar, Dominic A LaBella, Michael C Snider, et al.
Page
of 3